About Neutron Therapy Research Center (NTRC)
Working with international organizations,
we will establish the standard
protocol for BNCT.
The NTRC was established to develop new approaches to Boron Neutron Capture Therapy (BNCT). Scientists at the NTRC select and provide customized boron agents for BNCT based on genetic information and needs of individual patients for treating specific types of cancer. The NTRC is collaborating with the International Atomic Energy Agency (IAEA), Nagoya University, and other international organizations to establish standard procedures for BNCT for specific types of cancer.
IAEA: the international regulatory organization for radiotherapies.
Nagoya University: developing an efficient accelerator-based neutron generator.
What is neutron therapy?
BNCT is cutting-edge cancer therapy.
Neutron therapy is a concept that is an extension of BNCT. It is possible to severely damage cancer cells by neutron irradiation using low energy boron (10B) atoms that selectively target cancer cells, without affecting healthy ones. BNCT can be used to target malignant cancer tissues in which cancer cells are intricately-intertwined with normal cells. This treatment enhances the Quality of Life (QoL) of patients with cancer.
About our research
Aiming to develop a
new generation of BNCT.
For BNCT it is critically important to develop cancer-specific boron agents in order to provide appropriate boron agents for individual patients and develop efficient (accelerator-based) neutron facilities. The NTRC is collaborating with researchers—both from their own facilities and those at other institutes—to establish secure and reliable BNCT procedures.
